Just a quick reply to your comparison of the recent high flying IMU and our concerns with ANP's SP right now.
I simply put it down to different management styles. The majority of comments about ANP and its science come from forums like HC and we all know this type of comment attracts zero media interest. The management of IMU are quite different. The CEO, Leslie Chong, sends frequent personal emails to shareholders updating them on matters relating to their products which is greatly appreciated by investors and they find their way into the press and ASX announcements. These emails are quite regular occurrences.
Paul Hopper, Chairman of the Board, is likewise committed to a lot of publicity about the company.
As I have said before, IMHO our management need to get more proactive, like IMU, in this regard to attract more interest from potential investors and the media....... especially in view of the long period of upcoming trials when regular news flows will be critical to keeping the SP healthy.
Wont expand on this as it may cause negative discussion.
sincerely
Learner.
ANP Price at posting:
22.5¢ Sentiment: Buy Disclosure: Held
